                               SEQUENCE LISTING

<110> FORTE SUBSIDIARY, INC.
 
<120> COSMETIC COMPOSITIONS

<130> 53654-710.601

<140>
<141>

<150> 62/956,861
<151> 2020-01-03

<160> 9     

<170> PatentIn version 3.5

<210> 1
<211> 51
<212> DNA
<213> Roseomonas mucosa

<400> 1
cggcggcgga cagcccctcc accccatcct cgccgagccc gatgatgcta a                51


<210> 2
<211> 50
<212> DNA
<213> Roseomonas mucosa

<400> 2
cggcggcgga cagcccctcc actccacctc gccgagcccg atgatgctaa                  50


<210> 3
<211> 51
<212> DNA
<213> Roseomonas mucosa

<400> 3
cggcggcgga cagcccctcc accccgtcct cgccgagccc gatgatgcta a                51


<210> 4
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 4
caccggacag caggct                                                       16


<210> 5
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 5
gcggtggctt agcatcatc                                                    19


<210> 6
<211> 13
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 6
caccccatcc tcg                                                          13


<210> 7
<211> 13
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 7
caccccgtcc tcg                                                          13


<210> 8
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 8
ccctccaccc catcct                                                       16


<210> 9
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 9
ccctccactc catcct                                                       16


